Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
LONDON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024 at 9:35 a.m. Eastern Time.
伦敦，2024年11月26日（全球新闻网）-- kiniksa pharmaceuticals国际有限公司（纳斯达克：KNSA）今天宣布管理层将参加2024年12月3日上午9:35（东部时间）举行的第七届evercore ISI HealthCONx会议的炉边聊天。
A live webcast of Kiniksa's presentation will be accessible through the Investors section of the company's website at . A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event.
kiniksa的演示将通过该公司网站的投资者部分实时网络广播。活动重播将在大约48小时后在kiniksa的网站上提供。
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit .
ARCALYST是再生元制药公司的注册商标。
kiniksa pharmaceuticals是一家专注于发现、收购、开发和商业化治疗药物的商业阶段生物制药公司，为患有严重未满足医疗需求的患者提供治疗。 kiniksa pharmaceuticals的免疫调节资产基于强大的生物学基础或经过验证的机制，针对一系列未得到满足的心血管疾病和自身免疫情况，并具有差异化的潜力。欲了解更多信息，请访问。
Every Second Counts!
时间宝贵！
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
kiniksa投资者联系人
乔纳森·柯珊鲍姆
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
Kiniksa媒体联系人
Tyler Gagnon
(担任服务代理人的地址、邮政编码和电话号码，包括区域代码)
tgagnon@kiniksa.com
译文内容由第三方软件翻译。
